Judgment Made on First Instance for Docetaxel Patent Case
November 30, 2006After a four-year long trial proceeding, a judgment of first instance on the patent infringement case on anti-tumor medicine Taxotere was announced recently. The case was brought by Sanofi-Aventis, the third largest pharmaceutical company in the world, against Jiangsu Hengrui Pharmaceutical. Jiangsu Hengrui was charged with infringement upon two invention patents of drug Taxotere owned by Sanofi-Aventis. It was reported that Jiangsu Hengrui refused to accept the judgment and appealed to Shanghai People’s High Court on November 9, 2006.
Keywords
Headquarters
Add(Beijing):7th Floor,Scitech Place,22 Jianguomenwai Avenue,Beijing 100004,China
Tel: ＋86 10 5920 8888
Fax: ＋86 10 5920 8588
E-mail: mail@unitalen.com
Newsletter
Do not miss out on the latest announcements we've provided
Networking
Unitalen Mail Box ?2016 Unitalen Attorneys at Law 版權(quán)所有 集佳知識(shí)產(chǎn)權(quán)代理有限公司 京ICP備11033076號(hào) 京公網(wǎng)安備11010502020670